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Background: Double-hit lymphoma is a complex and highly aggressive sub-type of B-cell lymphoma, which has
recently been classified and is an area of active research interest due to the poor prognosis for patients with this
disease. It is characterized by the presence of both an activating MYC chromosomal translocation and a
simultaneous additional oncogenic translocation, often of the BCL2 gene. Recently, a cell line was established from
a patient with this complex lymphoma and analyzed using conventional tools revealing it contains both MYC and
BCL2 translocation events.
Findings: In this work, we reanalyzed the genome of the cell line using next generation whole genome
sequencing technology in order to catalogue translocations, insertions and deletions which may contribute to the
pathology of this lymphoma type.
Conclusions: We describe the cell line in much greater detail, and pinpoint the exact locations of the
chromosomal breakpoints. We also find several rearrangements within cancer-associated genes, which were not
found using conventional tools, suggesting that high throughput sequencing may reveal novel targets for therapy,
which could be used concurrently with existing treatments.
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Rearrangements in the human genome are a common
feature of B-cell lymphomas with recurrent reciprocal
chromosomal translocations present in approximately
40% of cases [1]. Certain translocations are considered
specific for certain types of lymphoma. For example,
t(8;14)(q24;q32) or variant translocations leading to con-
stitutive activation of the MYC transcription factor are a
hallmark of Burkitt's lymphoma and are present in 80-
95% of cases [2]. Furthermore, in follicular lymphomas,
a characteristic translocation occurs between chromo-
somes 14 and 18 (t(14;18)) which deregulates the
apoptosis-inhibiting gene BCL2 [3], resulting in a failure
to respond to cell death signals. In rare cases, these* Correspondence: lucia.cavelier@igp.uu.se
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reproduction in any medium, provided the orrearrangements are concurrent or sequential, and these
cases are therefore sometimes referred to as Double Hit
(DH) lymphoma. According to the most recent WHO
guidelines these tumors are classified as “B cell lymph-
oma unclassifiable with features intermediate between
DLBCL and BL [1]. Several cases of DH lymphoma have
been described "(e.g. [4-6]) and have attracted research
interest due to their unique cytogenetic features and
relatively poor prognosis. Recently a stable B-cell line
(U-2973) was established [7] from a DH lymphoma pa-
tient. This derived cell line does not necessarily repre-
sent the full clonality or tumorigenesis of the patient,
but retains the main translocations initially identified in
the patient. U-2973 was analyzed using conventional cyto-
genetic tools such as fluorescent in situ hybridization
(FISH), G-band staining and multicolor FISH. These
approaches showed concurrent translocations at t(8;12)
(q24;p12) and t(14;18)(q32;q21). However, the primaryl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the breakpoints of translocations can rarely be deter-
mined within tens or hundreds of kilobases. To address
this issue, we have repeated the analysis of U-2973 with
massive parallel sequencing on the SOLiD (ABI) platform.
In short, DNA from U-2973 was sheared and fragments
of on average 1kbp and 2.5kbp were selected for sequen-
cing. By sequencing both ends of DNA fragments, we can
capture not only translocations but also deletions and
insertions with a high level of resolution. As a result we
report a detailed map of chromosomal regions with ex-
tensive rearrangements not previously observed using
conventional methods. We also pinpoint the DNA se-
quence at the breakpoint of t(8;12) and describe a trans-
position of DNA from chromosome 20 to chromosome 8
which could not be detected using conventional tools.
Conventional analysis
The M-FISH and karyotyping were performed as the
DNA was extracted for the sequence analysis to verify
the karyotype reported earlier (Additional file 1: Figure S1A
and Additional file 2: Figure S2A) [7]. FISH hybridizations
using gene specific probes (MYC and IGH-BCL2) and
whole chromosome paint hybridizations (WCP8 and
WCP12; WCP 17 and WCP20) were performed to confirm
the findings of the M-FISH, on cells from an independent
culture. (Additional file 1: Figure S1B-D and Additional
file 2: Figure S2B). The analysis showed basically the same
karyotype as reported earlier with some discrepancies,
probably due to changes during cell culture namely the
reported trisomy 13, which we did not detect and a rear-
ranged chromosome 20, that contained extra material
from chromosome 17, which was earlier reported as con-
taining material from chromosome 19. All cells analyzed
showed the same karyotype in two independent cultures
indicating the presence of a single clone in the sample
used for DNA extraction and relative stability of the cell
line. However we cannot confirm that the cell line faith-
fully represents all the lymphoma cells in the patient at
diagnosis, but it rather constitutes a single clone selected
when establishing the cell line in culture. The karyotype
was further verified by SNP6 microarray analysis, which
did not detect any trisomy 13 and showed additional 17-q
material probably corresponding to the fragment incorpo-
rated into chromosome 20.
Detailed rearrangements
Deletions are characterized by a loss of DNA on one or
both alleles. Through sequencing, we discovered dele-
tions in U-2973 not previously described. We find for in-
stance exonic deletions in the potential oncogene PIGU
[8,9], and intronic deletions in PRKCA, which is overex-
pressed in some Burkitt's lymphomas [10]. Regionalintergenic deletions include 6.8kbp on chromosome 5,
4.5kbp on chromosome 1, and 7.2kbp on chromosome
8. For DNA gains, the major insertions are roughly
800bp into ANO3 on chromosome 11 and the protocad-
herin PCDH9 on chromosome 13. We also find two
cases of inversions involving exonic material in NKAIN3
and TSPAN8, a cell surface antigen, which were found
to be overexpressed in some human tumor cell lines
[11].
The characteristic rearrangements of a DH lymphoma
are the two chromosomal translocations involving MYC,
BCL2 och IGH. The translocation breakpoints (Figure 1)
on the derivative chromosome 8 der(8)t(8;12) were
sequenced using Sanger sequencing and located to nu-
cleotide coordinate 128835920 on chr8; 13kbp down-
stream of MYC and 45kbp upstream of PVT1, and at
position 25082917 on chr12; roughly 12kbp upstream of
LRMP, which appears to be deleted as a consequence of
the translocation. The reciprocal translocation der(12)
was not sequenced, but is positioned at roughly
129189kbp on chr8 and at approximately 25189kbp on
chr12. Thus, it appears that most of the CASC1 gene
has been lost, although one copy is likely to remain on
the third copy of chromosome 12 as is also the case for
LRMP. Most of the sequence of PVT1 has been lost
from the genome, since there are no remaining copies of
the original chromosome 8.
The t(14;18) translocation is also validated by both li-
braries and PCR, and subsequently Sanger sequenced.
One breakpoint lies within the IGH gene on chr14 and
the other roughly 20kbp upstream of BCL2 on chr18.
This is consistent with previous observations of IGH-BCL2
fusions in 96% of the blood sample [7] and in the
FISH-analysis on the cell line (Additional file 1: Figure S1C).
Furthermore, the breakpoint between chr14 and chr18 is
interspersed with a 31 bp sequence which has no hom-
ology to the reference (hg18) genome. This sequence may
have been extant in the genome before the translocation,
but is more likely to have been inserted as a consequence
of a non-homologous end joining of a double stranded
chromosomal break.
In the previous analysis [7], it was established that the
biallelic t(8;12) translocation involved MYC on chr8 and
potentially the LRMP gene on chr12, but more detailed
positions could not be determined. In this study, the
biallelic translocation could be more accurately deter-
mined and the positions of the breakpoints suggest that
LRMP may have been lost on the two derivative chro-
mosomes 12. However, potential regulatory elements of
LRMP may remain after the loss of sequence, and may
deregulate other genes. There are no previously identi-
fied promoter regions or regulatory elements in this re-
gion, but it is interesting to note that the mouse
ortholog to LRMP extends upstream to this
Figure 1 Detail of the t(8:12) translocations as validated by sequencing. This translocation has resulted in a possible heterozygous partial
loss of CASC1, and has an unknown effect on MYC. LRMP has also been lost from the derivative chromosome 12. C and T denotes the direction of
the centromere and telomere.
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to be expressed in germinal centre B-cells and in diffuse
large B-cell Lymphomas of the “germinal” center sub-
type [12], we hypothesize that regulatory elements ori-
ginally located upstream of the LRMP gene and
juxtaposed to the MYC-locus, might be involved in the
de-regulation of MYC. Interestingly, a recent report
shows a case of a primary B-cell lymphoma with a
t(8;12) translocation also involving MYC and LRMP
[13]. Although the exact position of the breakpoint at
LRMP was not determined, FISH analysis showed that
the 5’ region of LRMP was translocated to the MYC
locus also in this case. Thus it might be of interest to de-
termine the recurrence of MYC/LRMP rearrangements
in a larger number of B-cell lymphomas.
Furthermore, the sequence analysis strongly suggests a
translocation between chromosome 8 and 20. This
translocation is supported by a large number of reads
such as the previous translocations. However no t(8:20)
translocation could be observed by either FISH or karyo-
typing (see Additional file 2: Figure S2B). Since sequence
reads could rather represent an insertion of DNA from
one chromosome into the other, without otherwise dis-
rupting chromosome 8 or 20, we designed primers con-
sidering the two possible insertion structures with a
segment of 8 on 20 and vice versa. The PCR reactions
thereafter confirmed that roughly 5 kbp of intronic
DNA within the VPS13B gene on chromosome 8 was
inserted into chromosome 20 at position 58001229
and replacing some extant DNA including intronic
sequences and exon 10 of the CDH6gene (Additional file 3:
Figure S3). Whether or not this insertion has a driving role
is unclear, but this case illustrates the sensitivity of mate-
pair sequencing and also the need for a rigorous interpret-
ation of the results.
Besides the three sequence-verified major transloca-
tion events, we also find other events with lowersequence read support and therefore rather represent
transpositions of small regions of DNA, repetitive
sequences or subclonal populations. The full list of
translocations and affected genes is provided as Supple-
mentary Material. This may be useful in identifying pos-
sible recurrent aberrations when compared to other
lymphomas, and could also be informative when work-
ing with the U-2973 cell line. Thus comparisons to
sequences from other lymphomas might clarify which of
these events are recurrent and of pathogenic
importance.
Methods
The U-2973 cell line was established from a biopsy with
the informed consent of the patient and approved by the
local ethical review board (Uppsala 00–275) as described
in the original study [7]. DNA was prepared and
sequenced on the ABI SOLiD parallel sequencing system
according to the manufacturer's instructions. We pre-
pared and sequenced two mate-pair libraries; one with
an insert size of 2.5kbps, and one with an insert size of
1.5kbps. Thereafter, both ends of the fragment were
ligated to adaptors. Using the Corona Lite software
package (ABI), the 25bp reads were aligned to the
human reference genome (NCBI build 36) and reads
with unique matches on both ends were retained, result-
ing in a total of 119M read-pairs.
Additional files
Additional file 1: Figure S1A. G-band karyotype from the cell line
retrieved from the double-hit cell lymphoma. 47,XY,der(8)t(8;12)(q24.21;
p12.1)x2,+12,der(12)t(8;12)(q24.21; p12.1)x2,t(14;18)(q32;q21),der(20)t(17;20)
(q23;q13) chromosomes were harvested using a routine bone marrow
protocol with one hour colcemide treatment. The slides were
subsequently stained using standard Trypsin-Giemsa and karyotyped
using the Cytovision software. S1B-D, FISH hybridization of chromosomes
retrieved from the double-hit cell lymfoma. Chromosomes were
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DF probe (Abbott) and the WCP17 and WCP20 (Metasystems), according
to the manufacturer’s instructions. The pictures were retrieved using a
Zeiss microscope and analyzed using the ISIS software.
Additional file 2: Figure S2. Multicolor FISH and WCP hybridizations.
S2A. M-FISH hybridization showing the t(8;12), t(14;18) and the t(17;20)
translocations. S2B. WCP of chromosome 8 and 12, showing the two
derived chromosomes 8, the two derived chromosomes 12 and a normal
chromosome 12.
Additional file 3: Figure S3. Detail of an insertion of extragenous DNA
and deletion of material on chromosome 20. This rearrangement was
predicted by sequencing and undetected by conventional methods, but
yet confirmed by PCR.
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